Efficacy and Safety of Shenfu Injection for Severe Pneumonia in the Elderly: A Systematic Review and Meta-Analysis Based on Western and Eastern Medicine
Conclusion: SFI as an adjuvant may improve the total effective rate, APACHE II score, gas exchange, and predictors associated with COVID-19 progression, reducing mortality and safety concerns for elderly patients with severe pneumonia.PMID:36091817 | PMC:PMC9454296 | DOI:10.3389/fphar.2022.779942
Source: Pharmacological Reviews - Category: Drugs & Pharmacology Authors: Shihua Shi Fei Wang Bonan Chen Jie Pan Dan Luo Caixia Pei Demei Huang Xiaomin Wang Yilan Wang Zherui Shen Weihao Li Yongcan Wu Yacong He Zhenxing Wang Source Type: research
More News: Brain | Clinical Trials | COVID-19 | Databases & Libraries | Drugs & Pharmacology | Ginseng | Neurology | Physiology | Pneumonia | Science | Stroke | Study | von Willebrand Disease